0001225208-18-003075.txt : 20180215
0001225208-18-003075.hdr.sgml : 20180215
20180215181708
ACCESSION NUMBER: 0001225208-18-003075
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180213
FILED AS OF DATE: 20180215
DATE AS OF CHANGE: 20180215
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WILLIAMS RONALD A
CENTRAL INDEX KEY: 0001185243
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-03215
FILM NUMBER: 18619061
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: JOHNSON & JOHNSON
CENTRAL INDEX KEY: 0000200406
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 221024240
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 0101
BUSINESS ADDRESS:
STREET 1: ONE JOHNSON & JOHNSON PLZ
CITY: NEW BRUNSWICK
STATE: NJ
ZIP: 08933
BUSINESS PHONE: 732-524-2455
MAIL ADDRESS:
STREET 1: ONE JOHNSON & JOHNSON PLZ
CITY: NEW BRUNSWICK
STATE: NJ
ZIP: 08933
4
1
doc4.xml
X0306
4
2018-02-13
0000200406
JOHNSON & JOHNSON
JNJ
0001185243
WILLIAMS RONALD A
ONE JOHNSON & JOHNSON PLAZA
NEW BRUNSWICK
NJ
08933
1
Deferred Share Units
2018-02-13
4
A
0
1428.0000
0.0000
A
Common Stock
1428.0000
17477.2470
D
Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).
Linda E. King, as attorney-in-fact for Ronald A. Williams
2018-02-15